1. Home
  2. WST vs PBA Comparison

WST vs PBA Comparison

Compare WST & PBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • PBA
  • Stock Information
  • Founded
  • WST 1923
  • PBA 1997
  • Country
  • WST United States
  • PBA Canada
  • Employees
  • WST N/A
  • PBA N/A
  • Industry
  • WST Medical/Dental Instruments
  • PBA Oil & Gas Production
  • Sector
  • WST Health Care
  • PBA Energy
  • Exchange
  • WST Nasdaq
  • PBA Nasdaq
  • Market Cap
  • WST 15.6B
  • PBA 21.8B
  • IPO Year
  • WST N/A
  • PBA N/A
  • Fundamental
  • Price
  • WST $216.71
  • PBA $37.55
  • Analyst Decision
  • WST Buy
  • PBA Buy
  • Analyst Count
  • WST 7
  • PBA 1
  • Target Price
  • WST $331.67
  • PBA $59.00
  • AVG Volume (30 Days)
  • WST 690.0K
  • PBA 1.6M
  • Earning Date
  • WST 07-24-2025
  • PBA 08-07-2025
  • Dividend Yield
  • WST 0.38%
  • PBA 5.31%
  • EPS Growth
  • WST N/A
  • PBA N/A
  • EPS
  • WST 6.37
  • PBA 2.13
  • Revenue
  • WST $2,895,800,000.00
  • PBA $5,653,459,489.00
  • Revenue This Year
  • WST $3.38
  • PBA $13.50
  • Revenue Next Year
  • WST $5.85
  • PBA $0.62
  • P/E Ratio
  • WST $34.31
  • PBA $17.61
  • Revenue Growth
  • WST N/A
  • PBA 29.95
  • 52 Week Low
  • WST $187.43
  • PBA $34.13
  • 52 Week High
  • WST $352.33
  • PBA $43.44
  • Technical
  • Relative Strength Index (RSI)
  • WST 48.20
  • PBA 47.35
  • Support Level
  • WST $215.67
  • PBA $36.53
  • Resistance Level
  • WST $223.77
  • PBA $38.07
  • Average True Range (ATR)
  • WST 4.99
  • PBA 0.74
  • MACD
  • WST -0.52
  • PBA -0.02
  • Stochastic Oscillator
  • WST 19.10
  • PBA 29.64

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About PBA Pembina Pipeline Corp. (Canada)

Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its operations include transmission pipelines, oil and gas gathering, fractionation, storage, and natural gas liquid exports.

Share on Social Networks: